Biomea Fusion (BMEA) Operating Leases (2021 - 2025)
Biomea Fusion (BMEA) posted Operating Leases of $128000.0 for Q4 2025, down 97.9% sequentially from $6.1 million in Q3 2025, and down 98.09% YoY from $6.7 million in Q4 2024.
Biomea Fusion (BMEA) Operating Leases (2021 - 2025) Analysis & Trends
Biomea Fusion has reported Operating Leases for 5 years, with the latest figure at $128000.0 in Q4 2025.
- Quarterly Operating Leases fell 98.09% year-over-year to $128000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $128000.0 (down 98.09% YoY) and the FY2025 annual result came in at $128000.0, down 98.09% from the prior year.
- Operating Leases eased to $128000.0 in Q4 2025 per BMEA's latest filing, from $6.1 million in the prior quarter.
- Over five years, Operating Leases peaked at $10.7 million in Q1 2023 and troughed at $128000.0 in Q4 2025.
- A 5-year average of $5.3 million and a median of $6.3 million in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2025: Operating Leases soared 407.39% in 2023, then slumped 98.09% in 2025.
- Over 5 years, Operating Leases stood at $2.3 million in 2021, then retreated by 27.05% to $1.7 million in 2022, then soared by 369.71% to $7.8 million in 2023, then dropped by 14.53% to $6.7 million in 2024, then plunged by 98.09% to $128000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $128000.0, $6.1 million, and $6.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 128,000.00 |
| Sep 30, 2025 | 6.09 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 6.69 Mn |
| Sep 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Mar 31, 2024 | 7.93 Mn |
| Dec 31, 2023 | 7.83 Mn |
| Sep 30, 2023 | 9.27 Mn |
| Jun 30, 2023 | 10.01 Mn |
| Mar 31, 2023 | 10.74 Mn |
| Dec 31, 2022 | 1.67 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 2.29 Mn |
| Sep 30, 2021 | 2.43 Mn |
| Jun 30, 2021 | 2.58 Mn |